ICI PETCARE FLEAX PETS FLEA & TICK POWDER

Main information

  • Trade name:
  • ICI PETCARE FLEAX PETS FLEA & TICK POWDER
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ICI PETCARE FLEAX PETS FLEA & TICK POWDER
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • BIRDS | CAT | DOG | KENNEL, ANIMAL LIVING AREA PEST CONTROL | AVIARY BIRD | BITCH | BREEDERS | BROILERS | BUDGERIGARS | CANARIES
  • Therapeutic area:
  • STOCK PESTICIDE
  • Therapeutic indications:
  • FLEA | LOUSE | TICK | CTENOCEPHALIDES SPP. | GROUND FLEAS

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 33566
  • Last update:
  • 09-08-2016

10-8-2017

Bravecto® may cause convulsions in dogs on rare occasions

Bravecto® may cause convulsions in dogs on rare occasions

The European Medicines Agency has reviewed the adverse events of Bravecto®, a veterinary medicine used to treat flea and tick infestations in dogs. The conclusion is that the medicine may on very rare occasions cause convulsions in dogs – primarily in dogs with pre-existing epilepsy.

Danish Medicines Agency

16-5-2018

EU/3/03/140 (Novartis Europharm Limited)

EU/3/03/140 (Novartis Europharm Limited)

EU/3/03/140 (Active substance: Tobramycin (inhalation powder)) - Transfer of orphan designation - Commission Decision (2018)3031 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMEA/OD/072/02/T/02

Europe -DG Health and Food Safety